Skip to main content
. 2021 Mar 25;12:642087. doi: 10.3389/fimmu.2021.642087

Figure 1.

Figure 1

Patients with HLA-loss at relapse. Follow-up of patients in which HLA-loss was identified retrospectively (A) and patients identified prospectively, in which HLA-loss could be used to drive therapeutic decisions (B). Pt, Patient; HSCT, hematopoietic stem cell transplantation; DLIs, Donor lymphocyte infusions.